Revolution Medicines
The Director, Global Insights at Revolution Medicines will lead the development and execution of the global insights roadmap, translating market research into strategic recommendations that influence product and portfolio decisions across oncology pipelines. This role collaborates cross‑functionally with commercial development, clinical development, portfolio management, and medical affairs to support early‑stage decision making and drive business growth.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
2014
Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.
Victory Capital Management Inc. Trims Stock Holdings in Revolution Medicines, Inc. $RVMD
13 hours ago
Revolution Medicines Trials, Funding Capacity And Insider Moves Shape Risk Outlook
5 days ago
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Revolution Medicines.
12% above the average for this role
Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs
1 week ago
Global Analytics & Insights Director – Oncology
AstraZeneca
Director, Competitive Intelligence & Insights - Oncology
Vir Biotechnology
Global Analytics & Insights Director – Oncology
AstraZeneca
Global Medical Affairs Leader – Emerging Portfolio Strategy
AstraZeneca
Global Analytics & Insights Director – Oncology
AstraZeneca
Senior Director, Oncology Search & Evaluation
BioLife Plasma Services